Clinical Trial Update: Metformin as a Neuroprotective Therapy for Glaucoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating metformin as a neuroprotective therapy for glaucoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Christopher Kai Shun Leung | Conditions: Glaucoma | Phase 2 | Status: RECRUITING